Shareholding disclosure
Santhera Pharmaceuticals Holding AG
Declared position
53.79%
Threshold
Crossed downwards
Timeline
Published
17.04.2020
Transaction
07.04.2020
Voting rights breakdown
Voting rights acquired10.77%
Voting rights sold53.79%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAK4F00068
Beneficial owner
Santhera Pharmaceuticals Holding AG
Declared address
Santhera Pharmaceuticals Holding AG, Pratteln
Erwerb und Veräusserung von Aktien am 8. April 2020
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open